MMManuel Fernández Martínez

Manuel Fernández Martínez

*This is an algorithmically generated author record based on publicly available information.

Manuel Fernández Martínez has a total of 154 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Linfomatosis meníngea como recidiva tardía de macroglobulinemia de Waldenström

    by Juan José Alonso Alonso, Araceli Cánovas Fernández, Manuel Fernández Martínez, Raquel Pérez Garay

  • Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene

    by Johanne Hatteland Somme, Ana Molano Salazar, Amaia Gonzalez, Beatriz Tijero, Koldo Berganzo, Elena Lezcano, Manuel Fernandez Martinez, Juan Jose Zarranz, Juan Carlos Gómez-Esteban


  • Cognitive and Neuroimaging Profiles in Mild Cognitive Impairment and Alzheimer's Disease: Data from the Spanish Multicenter Normative Studies (NEURONORMA Project)

    by Gonzalo Sánchez-Benavides, Jordi Peña-Casanova, Marta Casals-Coll, Nina Gramunt, José L. Molinuevo, Beatriz Gómez-Ansón, Miguel Aguilar, Alfredo Robles, Carmen Antúnez, Carlos Martínez-Parra, et al.

    The aim of this study was to characterize the neuropsychological and neuroimaging profiles of mild cognitive impairment (MCI) and Alzheimer's disease (AD) patients, and to study the magnitude of the differences by comparing both outcomes with healthy subjects in a cross-sectional manner. Five hundred and thirty-five subjects (356 cognitively normal adults (CONT), 79 MCI, and 100 AD) were assessed with the NEURONORMA neuropsychological battery. Thirty CONT, 23 MCI, and 23 AD subjects from this sample were included in the neuroimaging substudy. Patients' raw cognitive scores were converted to age and education-adjusted scaled ones (range 2-18) using co-normed reference values. Medians were plotted to examine the cognitive profile. MRIs were processed by means of FreeSurfer. Effect size indices (Cohen's d) were calculated in order to compare the standardized differences between patients and healthy subjects. Graphically, the observed cognitive profiles for MCI and AD groups produced near to parallel lines. Verbal and visual memories were the most impaired domains in both groups, followed by executive functions and linguistic/semantic ones. The largest effect size between AD and cognitively normal subjects was found for the FCSRT (d = 4.05, AD versus CONT), which doubled the value obtained by the best MRI measure, the right hippocampus (d = 1.65, AD versus CONT). Our results support the notion of a continuum in cognitive profile between MCI and AD. Neuropsychological outcomes, in particular the FCSRT, are better than neuroimaging ones at detecting differences among subjects.


  • Open Access

    Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE ɛ4 carriers: a case–control study

    by Manuel Fernández-Martínez, Xabier Elcoroaristizabal Martín, Elisa Blanco Martín, Luis Galdos Alcelay, Iratxe Ugarriza Serrano, Fernando Gómez Busto, Maite Álvarez-Álvarez, Ana Molano Salazar, Rocio Bereincua Gandarias, Sandra Inglés Borda, et al.

    Objectives: Examine the role of single nucleotide polymorphisms (SNPs) in the oestrogen receptor (ER) genes: rs9340799, rs2234693, rs2228480 (in theESR1gene) and rs4986938 (in theESR2gene) as a risk factor for amnesic mild cognitive impairment (MCIa) and Alzheimer's disease (AD) and its possible association with the apolipoprotein E (APOE)gene.Design: We have investigated the independent and combined association of different alleles of the oestrogen receptor genes and APOE*ɛ4 allele with cognitive impairment using a case–control design.Setting: Participants were prospectively recruited from the neurology departments of several Basque Country hospitals.Participants: This study comprised 816 Caucasian participants who were aged 50 years and older: 204 MCIa, 350 sporadic patients with AD and 262 healthy controls.Primary and secondary outcome measures: Clinical criteria and neuropsychological tests were used to establish the diagnostic groups (MCIa, AD and healthy controls). A dichotomous variable was used for each allele and genotype and the association with MCIa and AD was established using Logistic Regression Models.Results: Neither alleles nor genotypes of SNPs rs9340799, rs2234693, rs2228480 and rs4986938 of oestrogen receptor genes (ESR1andESR2) are independently associated with the risk of MCIa or AD. However, the genetic profile created with the combination of the less represented alleles of these SNPs (expressed as XPAA) was associated with an increased risk for MCIa (OR=3.30, 95% CI 1.28 to 8.54, p=0.014) and AD (OR=5.16, 95% CI 2.19 to 12.14, pESR1andESR2SNPs are associated with an increased risk for MCIa and AD in women APOEɛ4 allele carriers.


  • Prevalence and European comparison of dementia in a ≥75-year-old composite population in Spain

    by J. Virués-Ortega, J. de Pedro-Cuesta, S. Vega, M. Seijo-Martínez, P. Saz, F. Rodríguez, Á. Rodríguez-Laso, R. Reñé, S. P. de Las Heras, R. Mateos, et al.

    Virués‐Ortega J, de Pedro‐Cuesta J, Vega S, Seijo‐Martínez M, Saz P, Rodríguez F, Rodríguez‐Laso Á, Reñé R, de las Heras SP, Mateos R, Martínez‐Martín P, Mahillo‐Fernández I, López‐Pousa S, Lobo A, Reglà JL, Gascón J, García FJ, Fernández‐Martínez M, Boix R, Bermejo‐Pareja F, Bergareche A, Sánchez‐Sánchez F, de Arce A, del Barrio JL; On behalf of the Spanish Epidemiological Studies on Ageing Group. Prevalence and European comparison of dementia in a ≥75‐year‐old composite population in Spain. Acta Neurol Scand: 2011: 123: 316–324. © 2010 John Wiley & Sons A/S. Objectives – To estimate dementia prevalence in Spain. Materials and methods – Nine probabilistic and geographically defined samples participated. A screening design based on the MMSE was implemented. Positively screened individuals underwent clinical evaluation. The total number of cases in Spain was estimated. Prevalence was confronted to that of other European countries. Results – Five hundred and forty‐six persons aged ≥75 participated, 49 had dementia (35 with Alzheimer’s disease [AD], 10 with vascular dementia [VD], 4 other; 25 first diagnosed in the study). Age‐ and sex‐adjusted prevalence and estimated nationwide cases were 7.5% (95% CI 5.4–9.7), 5.6 (95% CI 3.7–7.5) and 1.4 (95% CI 0.5–2.3), and 290,000 (95% CI 208,000–372,000), 214,000 (95% CI 141,000–288,000) and 54,000 (95% CI 20,000–88,000) for dementia, AD and VD, respectively. Conclusions – Dementia prevalence in Spain is comparable to other European populations, while a high number of undiagnosed cases live in the community. The potential impact of Mediterranean diet, hypertension control and decreasing vascular risk factors is discussed.


  • Open Access

    Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment

    by the COOPERA Study Group, Manuel Fernández, Ana L Gobartt, Montse Balañá

    Behavioural and psychological symptoms of dementia (BPSD) are non-cognitive symptoms commonly associated to Alzheimer's disease (AD). The characterization of the clinical profile of AD patients might help to better understand disease evolution and to improve diagnosis and treatment. Thus, the aim of the present study is to describe the clinical profile of AD patients, and to correlate the presence of BPSD with the severity of the disease.


  • Prevalence of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimers Disease, and its Relationship with Cognitive Impairment

    by M. Fernandez-Martinez, A. Molano, J. Castro, J. J. Zarranz

    Objective The study aimed to describe the prevalence of Neuropsychiatric symptoms (NPS) in Alzheimers disease (AD), amnestic mild cognitive impairment (MCI) and controls using the 12-item Neuropsychiatric Inventory (NPI) and to analyze the relationships between neuropsychiatric symptoms with specific neuropsychological tests.Patients and methods; We prospectively studied 485 patients from the Memory Unit in Cruces Hospital (Spain), 344 met the criteria of NINCDS-ADRDA for probable AD (99 were classified as mild and 245 as moderate-severe), 91 for MCI and 50 were controls. Mini-mental State Examination (MMSE) and CDR (Clinical Dementia Rating) were used to evaluate global cognitive function and to classify the severity of cognitive impairment. The neuropsychological test battery included memory test, verbal fluency, visuoespatial skills and daily living scales. The 12-items Neuropsychiatric Inventory (NPI) version was used to assess neuropsychiatric symptoms. All patients underwent a neuroimaging study (CT scan and/or MRI). Patients were not treated with antidementia or psychotropic drugs. Results;Apathy and depression were more prevalent NPS in moderate-severe AD (78.4% and 44.1%, respectively), mild AD (64.6% and 41.4%, respectively) and MCI (50.5% and 33%, respectively) patients than in controls (6% and 8%, respectively). The prevalence and the mean scores of all symptoms increased along the severity of the disease, except for sleep and appetite disorders. In patients with mild AD a relationship was found between the presence of NPS and RDRS-2 scale (p = 0.003); and between NPS and RDRS-2 (p = 0.029) and SS-IQCODE scales (p = 0.039) in moderate-severe patients.Conclusions; NPS were more prevalent in AD and MCI patients than in controls. In AD and MCI patients apathy and depression were the most prevalent NPS. The prevalence and the mean scores of all symptoms gradually increased along the severity of the disease, except for sleep and appetite disorders. We have no found a relationship between neuropsycological test and the presence of NPS, but in patients with mild and moderate-severe AD there is a relationship with daily living scales.


  • Open Access

    Prevalence of dementia and major dementia subtypes in Spanish populations: A reanalysis of dementia prevalence surveys, 1990-2008

    by Jesús de Pedro-Cuesta, Javier Virués-Ortega, Saturio Vega, Manuel Seijo-Martínez, Pedro Saz, Fernanda Rodríguez, Angel Rodríguez-Laso, Ramón Reñé, Susana Pérez de Las Heras, Raimundo Mateos, et al.

    This study describes the prevalence of dementia and major dementia subtypes in Spanish elderly. We identified screening surveys, both published and unpublished, in Spanish populations, which fulfilled specific quality criteria and targeted prevalence of dementia in populations aged 70 years and above. Surveys covering 13 geographically different populations were selected (prevalence period: 1990-2008). Authors of original surveys provided methodological details of their studies through a systematic questionnaire and also raw age-specific data. Prevalence data were compared using direct adjustment and logistic regression. The reanalyzed study population (aged 70 year and above) was composed of Central and North-Eastern Spanish sub-populations obtained from 9 surveys and totaled 12,232 persons and 1,194 cases of dementia (707 of Alzheimer's disease, 238 of vascular dementia). Results showed high variation in age- and sex-specific prevalence across studies. The reanalyzed prevalence of dementia was significantly higher in women; increased with age, particularly for Alzheimer's disease; and displayed a significant geographical variation among men. Prevalence was lowest in surveys reporting participation below 85%, studies referred to urban-mixed populations and populations diagnosed by psychiatrists. Prevalence of dementia and Alzheimer's disease in Central and North-Eastern Spain is higher in females, increases with age, and displays considerable geographic variation that may be method-related. People suffering from dementia and Alzheimer's disease in Spain may approach 600,000 and 400,000 respectively. However, existing studies may not be completely appropriate to infer prevalence of dementia and its subtypes in Spain until surveys in Southern Spain are conducted.


  • Open Access

    The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers

    by Manuel Fernández Martínez, Xabier Elcoroaristizabal Martín, Luís Galdos Alcelay, Jessica Castro Flores, Juan María Uterga Valiente, Begoña Indakoetxea Juanbeltz, María Ángeles Gómez Beldarraín, Josefa Moraza López, María Carmen Gonzalez-Fernández, Ana Molano Salazar, et al.

    The aim of this study is to examine the influence of the catechol-O-methyltranferase (COMT) gene (polymorphism Val158 Met) as a risk factor for Alzheimer's disease (AD) and mild cognitive impairment of amnesic type (MCI), and its synergistic effect with the apolipoprotein E gene (APOE).


  • Open Access

    Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country-Spain)

    by Manuel Fernández Martínez, Jessica Castro Flores, Susana Pérez de Las Heras, Aitziber Mandaluniz Lekumberri, María Gordejuela Menocal, Juan José Zarranz Imirizaldu

    Prevalence of degenerative dementias and dementias associated with cerebrovascular disease is increasing. Dementia is one of the most significant public health problem. In recent years, the role of vascular risk factors (hypertension, diabetes mellitus and hypercholesterolemia) and depression has been evaluated.